N.E.W. Advisory Services’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$76K Sell
1,586
-528
-25% -$22.7K 0.01% 318
2026
Q1
$77.7K Hold
2,114
0.01% 313
2025
Q4
$108K Buy
2,114
+100
+5% +$5.11K 0.01% 273
2025
Q3
$112K Hold
2,014
0.01% 236
2025
Q2
$139K Buy
2,014
+486
+32% +$33.1K 0.01% 216
2025
Q1
$106K Buy
+1,528
New +$126K 0.01% 271

Other funds holding NVO

N.E.W. Advisory Services's NVO Position: Q2 2026 in Review

N.E.W. Advisory Services reduced its Novo Nordisk (NVO) stake by 25% in Q2 2026, selling an estimated $22.7K and leaving 1,586 shares worth $76K. The position accounts for 0.01% of the portfolio, ranked #318.

N.E.W. Advisory Services first reported a position in NVO in Q1 2025 and has held it in 6 quarters since. The position peaked at $139K in Q2 2025. 959 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • N.E.W. Advisory Services held 1,586 shares of Novo Nordisk worth $76K as of Q2 2026.
  • N.E.W. Advisory Services sold 528 Novo Nordisk shares in Q2 2026, an estimated $22.7K.
  • Novo Nordisk made up 0.01% of N.E.W. Advisory Services's portfolio in Q2 2026, its #318 holding.
  • N.E.W. Advisory Services first reported a position in Novo Nordisk in Q1 2025 and has held it in 6 quarters since.
  • N.E.W. Advisory Services's Novo Nordisk position peaked at $139K in Q2 2025.
  • 959 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on N.E.W. Advisory Services's 13F filing for Q2 2026, filed 6 Aug 2026.